Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Waldenstrom Macroglobulinemia 2Rectal Neoplasms 2Pancreatic Neoplasms 2Lymphoma, Follicular 2Lymphoma, B-Cell, Marginal Zone 2Fallopian Tube Neoplasms 2Colonic Neoplasms 2Carcinoma, Ovarian Epithelial 2Unspecified Childhood Solid Tumor, Protocol Specific 1Stomach Neoplasms 1Lymphoma, Non-Hodgkin 1Lymphoma, Mantle-Cell 1Lymphoma, Large-Cell, Anaplastic 1Leukemia, Lymphocytic, Chronic, B-Cell 1Intraocular Lymphoma 1Ependymoma 1Colorectal Neoplasms 1

Interventions

Rituximab 5Vorinostat 3Lenalidomide 3Irinotecan 3Filgrastim 3Dasatinib 3tanespimycin 2laromustine 2ixabepilone 2fludarabine phosphate 2entinostat 2belinostat 2Radiotherapy 2Paclitaxel 2Etoposide 2Cyclophosphamide 2Bortezomib 2Bevacizumab 2vandetanib 1tirbanibulin 1pyroxamide 1pomalidomide 1ontuxizumab 1obatoclax 1methoxyamine 1imetelstat 1ibrutinib 1etaracizumab 1dexamethasone acetate 1dexamethasone 21-phosphate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1 × Intraocular Lymphoma × Enzyme-Linked Immunosorbent Assay × Clear all
NCT00720135 2015-06-08

Fusion Protein Cytokine Therapy After Rituximab in Treating Patients With B-Cell Non-Hodgkin Lymphoma

City of Hope Medical Center

Phase 1 Completed
9 enrolled
Lymphoid

Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Waldenstrom Macroglobulinemia, Lymphoma, Large-Cell, Anaplastic, Lymphoma, B-Cell, Marginal Zone, Intraocular Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡